As the European Union moves to operationalise the European Health Data Space (EHDS), a framework with the potential to transform cross-border health research, the pathway for participation by third ...

You may be familiar with the term whole genome sequencing (WGS). Instead of ordering specific genetic tests, based on the phenotypes of the patient, WGS allowed more of the genome to be interrogated, ...

The use of polygenic scores in healthcare is divisive and regularly contested. Some clinicians and researchers are exploring how PGS can be used in specific contexts and see real value in the added ...

Potential fallout from the recent UK Biobank data exposure – and similar cases – highlights that governance cannot be treated as an administrative add on. It is foundational infrastructure on which ...

Quantum computing, a type of quantum technology, is poised to address pressing challenges in the healthcare sector. For example, while the average cost of the drug development pipeline has tripled ...

Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...

The optimism is not unfounded. In specific, well-defined clinical scenarios, polygenic scores are beginning to demonstrate some tangible utility. For cardiovascular disease, MI-GENES, a 10-year follow ...

Catherine Barnard, FBA, FLSW, FRSA is Professor of European law and fellow of Trinity College, Cambridge and Director of the Centre for European Legal Studies. She is the author of EU Employment Law ...

A patient arriving in A&E or another clinical setting, with suspected or known infection and the risk of sepsis, requires immediate action. Antibiotic admission more than one hour after suspected ...

Sepsis is a critical global healthcare challenge, marked by complex and rapidly evolving symptoms, which can escalate with alarming speed leading to multi-organ failure. This leaves only a narrow ...